Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
View Session ViewAttendees 36

Adult ID

Epidemiology & Infection Control

Pediatric ID

Trainee

Transplant
Symposium

95 - Big Beasts of Skin & Soft Tissue Infections

Friday, October 1, 2021
2:45 PM - 4:00 PM EDT

    Moderator(s)

  • Michelle Floris-Moore, MD, MS

    Associate Professor
    University of North Carolina at Chapel Hill
    Chapel Hill, NC, United States

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

    • Speaker(s)

  • JT

    Jeffrey Tessier

    I do not have any relevant financial / non-financial relationships with any proprietary interests.

  • Henry Chambers, MD

    Professor of Medicine, Emeritus
    UC San Francisco School of Medicine
    San Francisco, CA, United States

    Merck (Individual(s) Involved: Self): DSMB member, Other Financial or Material Support; Moderna (Individual(s) Involved: Both Myself and my Spouse/Partner): Shareholder

  • Trevor Van Schooneveld, MD, FSHEA, FACP

    Professor, Division of Infectious Diseases
    Internal Medicine
    University of Nebraska Medical Center
    Omaha, NE, United States

    BioFire (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Insmed (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Scientific Research Study Investigator; Rebiotix (Individual(s) Involved: Self): Scientific Research Study Investigator

Participants should be aware of the following financial/non-financial relationships:
Michelle Floris-Moore, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Jeffrey Tessier: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Henry Chambers, MD: Merck (Individual(s) Involved: Self): DSMB member, Other Financial or Material Support; Moderna (Individual(s) Involved: Both Myself and my Spouse/Partner): Shareholder
Trevor C. Van Schooneveld, MD, FACP: BioFire (Individual(s) Involved: Self): Consultant, Scientific Research Study Investigator; Insmed (Individual(s) Involved: Self): Scientific Research Study Investigator; Merck (Individual(s) Involved: Self): Scientific Research Study Investigator; Rebiotix (Individual(s) Involved: Self): Scientific Research Study Investigator

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
ACPE Credits: ACPE 1.25 Knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-21-001-H01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:
  • recognize signs and symptoms of life-threatening skin and soft tissue infections
  • describe appropriate treatment of severe skin and soft tissue infections
  • differentiate between SSTIs and non-infectious conditions that mimic skin/soft tissue infection

Presentations:

  • Gram-Negative and Mixed Necrotizing Soft Tissue Infections

    Speaker: Jeffrey Tessier

  • Gram-Positive Necrotizing Soft Tissue Infections

    Speaker: Henry Chambers, MD – UC San Francisco School of Medicine

  • SSTI Imposters

    Speaker: Trevor C. Van Schooneveld, MD, FACP – University of Nebraska Medical Center